Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dinesh Kannabhiran"'
Autor:
Devan Makati, James Akers, Muhammad Aljuhani, Bethany Pellegrino, Rebecca Schmidt, Khaled Shawwa, Dinesh Kannabhiran
Publikováno v:
Journal of nephrology. 35(4)
The epidemiology of ANCA-associated vasculitis (AAV) varies by ethnicity and region. Environmental exposure has been implicated in the pathophysiology of MPO-AAV. The aim of this study was to evaluate the epidemiology of AAV and explore a potential r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f8edf2ac064a947f414b551d36f119
https://pubmed.ncbi.nlm.nih.gov/34989976
https://pubmed.ncbi.nlm.nih.gov/34989976
Autor:
Bethany Pellegrino, Dinesh Kannabhiran, Jesse Thompson, Khaled Shawwa, Muhammad Aljuhani, Abigail Hoff, Rebecca J. Schmidt, Devan Makati
Publikováno v:
Rheumatology international. 41(5)
The objective of this study is to evaluate the association between antineutrophil cytoplasmic autoantibody (ANCA) subtype and ANCA titers on clinical outcomes and disease activity among a cohort of patients from Central Appalachia diagnosed with ANCA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d90f4a768bfbf14bce5e7db4f68215
https://pubmed.ncbi.nlm.nih.gov/33585954
https://pubmed.ncbi.nlm.nih.gov/33585954
Autor:
Dinesh Kannabhiran
Publikováno v:
Archives of Pharmacy & Pharmacology Research. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009805335cbc129dca88e9601a11b8e5
https://doi.org/10.33552/appr.2019.02.000530
https://doi.org/10.33552/appr.2019.02.000530
Autor:
Surya V. Seshan, Dinesh Kannabhiran, Darshana Dadhania, Sean Campbell, Rex Friedlander, David Epstein, Vijay K. Sharma, John R. Lee, Joseph E. Schwartz, Sandip Kapur, Manikkam Suthanthiran, Thangamani Muthukumar, Meredith J. Aull
Publikováno v:
Transplantation. 99(6)
BACKGROUND Characteristics of pretransplant antibodies directed at donor human leukocyte antigen (HLA) donor-specific antibodies (DSA) associated with adverse outcomes in kidney transplant recipients are being elucidated but uncertainties exist. METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df1c4b2a293781502a4007ab39b5bd7
https://pubmed.ncbi.nlm.nih.gov/25629531
https://pubmed.ncbi.nlm.nih.gov/25629531
Autor:
Dinesh, Kannabhiran, Matthew J, Everly, Jennifer K, Walker-McDermott, Sue, Tiongko, Rex, Friedlander, Prabhakar, Putheti, Vijay, Sharma, Darshana, Dadhania
Publikováno v:
Clinical transplants.
The predominant anti-HLA IgG subclass during antibody mediated rejection episodes is IgG1. Class I DSA IgG subclasses respond to single cycle of bortezomib-based therapy more frequently as compared to Class II DSA IgG subclasses. High titer Class II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::817b139df991b4c25ec89ead42227a9b
https://pubmed.ncbi.nlm.nih.gov/23721027
https://pubmed.ncbi.nlm.nih.gov/23721027
Publikováno v:
Current Concepts in Kidney Transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c7b9654ff8255bd159e5477abdd4c5
http://www.intechopen.com/articles/show/title/transplanting-against-histocompatibility-barriers
http://www.intechopen.com/articles/show/title/transplanting-against-histocompatibility-barriers
